Not applicableUnknownNCT05539300What this trial is testingPSMA Response in Metastasized Hormone Sensitive Prostate Cancer - EnzalutamideWho this might be right forProstate Cancer UMC Utrecht 150
Testing effectiveness (Phase 2)Looking for participantsNCT05873192What this trial is testingPresurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate CancerWho this might be right forProstate Cancer M.D. Anderson Cancer Center 30
Early research (Phase 1)Study completedNCT04086758What this trial is testingA Pharmacokinetic Study of Zolbetuximab (IMAB362) in Chinese Subjects With Locally Advanced Unresectable or Metastatic Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaWho this might be right forGastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma Astellas Pharma China, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT02815033What this trial is testingImaging Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving EnzalutamideWho this might be right forProstate Cancer Metastatic The European Uro-Oncology Group 66
Early research (Phase 1)Ended earlyNCT02500901What this trial is testingEnzalutamide and Niraparib in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC)Who this might be right forMetastatic Prostate Cancer Paul Mathew, MD 2
Large-scale testing (Phase 3)UnknownNCT04139772What this trial is testingDocetaxel or Hormone Therapy as Second Line Treatment in Patients With Asymptomatic or Oligosymptomatic Metastatic Castration-resistent Prostate Cancer (mCRPC) Progressing After Abiraterone or Enzalutamide.Who this might be right forMetastatic Castration-resistent Prostate Cancer National Cancer Institute, Naples 18
Not applicableUnknownNCT02922218What this trial is testingPROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide.Who this might be right forAdvanced Prostate CancerCastration ResistantEnzalutamide Centro Nacional de Investigaciones Oncologicas CARLOS III 187
Not applicableNot Yet RecruitingNCT07779590What this trial is testingLearn About the Outcomes Between Study Medicines, Enzalutamide and Darolutamide Among Men With Metastatic Castration Sensitive Prostate Cancer (mCSPC)Who this might be right forMetastatic Castration Sensitive Prostate Cancer (mCSPC) Pfizer 4,700
Testing effectiveness (Phase 2)Looking for participantsNCT06844383What this trial is testingTalazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or DarolutamideWho this might be right forProstate Cancer (Adenocarcinoma)mCRPC (Metastatic Castration-resistant Prostate Cancer) Prostate Cancer Clinical Trials Consortium 126
Testing effectiveness (Phase 2)Ended earlyNCT03437941What this trial is testingStudy to Evaluate Exicorilant (CORT125281) in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate CancerWho this might be right forMetastatic Castration-Resistant Prostate Cancer Corcept Therapeutics 39
Testing effectiveness (Phase 2)Study completedNCT02814968What this trial is testingPET/CT and WB MRI for Staging and Response in CRPC Patients Receiving EnzalutamideWho this might be right forProstate Cancer Metastatic The European Uro-Oncology Group 66
Testing effectiveness (Phase 2)Looking for participantsNCT06702995What this trial is testingStudy of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate CancerWho this might be right forMetastatic Castrate-Resistant Prostate CancermCRPC (Metastatic Castration-resistant Prostate Cancer) Evopoint Biosciences Inc. 307
Testing effectiveness (Phase 2)Study completedNCT05730712What this trial is testingPertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate CancerWho this might be right forCastration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8 Mayo Clinic 7
Early research (Phase 1)Study completedNCT03674814What this trial is testingStudy of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate CancerWho this might be right forProstate Cancer University of Chicago 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT04557449What this trial is testingStudy to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid TumorsWho this might be right forLiposarcomaProstate CancerBreast Neoplasms+1 more Pfizer 362
Testing effectiveness (Phase 2)Study completedNCT01981122What this trial is testingSipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate CancerWho this might be right forMetastatic Prostate Cancer Dendreon 52
Large-scale testing (Phase 3)Active Not RecruitingNCT02446405What this trial is testingEnzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate CancerWho this might be right forProstatic Neoplasms University of Sydney 1,125
Testing effectiveness (Phase 2)Study completedNCT01664923What this trial is testingSafety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate CancerWho this might be right forProstate Cancer Pfizer 396
Large-scale testing (Phase 3)Study completedNCT02294461What this trial is testingAn Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer ParticipantsWho this might be right forProgressive Metastatic Prostate Cancer Astellas Pharma Inc 395
Testing effectiveness (Phase 2)Study completedNCT02953860What this trial is testingFulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast CancerWho this might be right forBreast Cancer University of Colorado, Denver 32